
Closing the Revolving Door at HHS
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
The Food and Drug Administration plans to ban employees of regulated companies, including drug manufacturers, from serving on the agency’s advisory committees. The new policy is aimed at combating industry influence and conflicts of interest, but will it make a difference? We are joined by Genevieve Kanter, an Associate Professor at the USC Price School, who has researched conflicts of interest at the FDA as well as the “revolving door” of people moving between jobs in government and regulated industries.
What listeners say about Closing the Revolving Door at HHS
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.